Robert J Gould - Net Worth and Insider Trading
Robert J Gould Net Worth
The estimated net worth of Robert J Gould is at least $4 Million dollars as of 2024-04-27. Robert J Gould is the Interim President & CEO of Fulcrum Therapeutics Inc and owns about 499,864 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $4 Million. Robert J Gould is also the Director of Epizyme Inc and owns about 0 shares of Epizyme Inc (EPZM) stock worth over $0. Details can be seen in Robert J Gould's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert J Gould has not made any transactions after 2023-01-13 and currently still holds the listed stock(s).
Transaction Summary of Robert J Gould
Robert J Gould Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert J Gould owns 3 companies in total, including Fulcrum Therapeutics Inc (FULC) , Epizyme Inc (EPZM) , and Turnstone Biologics Corp (TSBX) .
Click here to see the complete history of Robert J Gould’s form 4 insider trades.
Insider Ownership Summary of Robert J Gould
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2023-01-13 | director & President & CEO |
| EPZM | Epizyme Inc | 2015-12-30 | director & 10 percent owner & President and CEO |
| TSBX | Turnstone Biologics Corp | 2023-07-20 | director |
Robert J Gould Latest Holdings Summary
Robert J Gould currently owns a total of 2 stocks. Among these stocks, Robert J Gould owns 499,864 shares of Fulcrum Therapeutics Inc (FULC) as of January 13, 2023, with a value of $4 Million and a weighting of 100%. Robert J Gould also owns 0 shares of Epizyme Inc (EPZM) as of December 30, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Robert J Gould
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2023-01-13 | 499,864 | 7.14 | 3,569,029 |
| EPZM | Epizyme Inc | 2015-12-30 | 0 | 1.47 | 0 |
Holding Weightings of Robert J Gould
Robert J Gould Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert J Gould has made a total of 17 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 6,766 shares on January 13, 2023, which brought Robert J Gould around $101,490.
According to the SEC Form 4 filings, Robert J Gould has made a total of 0 transactions in Epizyme Inc (EPZM) over the past 5 years. The most-recent trade in Epizyme Inc is the sale of 32,108 shares on December 30, 2015, which brought Robert J Gould around $578,265.
Insider Trading History of Robert J Gould
- 1
Robert J Gould Trading Performance
Robert J Gould Ownership Network
Ownership Network List of Robert J Gould
Ownership Network Relation of Robert J Gould
Robert J Gould Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Robert J Gould is the director & President & CEO of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Robert J Gould made 1 insider transaction in Fulcrum Therapeutics Inc (FULC) with a net sale of 6,766. Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 4,609,704 shares made by Ra Capital Healthcare Fund Lp , a net sale of 5,094 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 4,884 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 43,360 shares, with a net purchase of 38,476 shares. During the past 18 months, 11,860 shares of Fulcrum Therapeutics Inc (FULC) were sold and 4,653,064 shares were bought by its insiders, resulting in a net purchase of 4,641,204 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Robert J Gould Mailing Address
Above is the net worth, insider trading, and ownership report for Robert J Gould. You might contact Robert J Gould via mailing address: C/o Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
